Search

everythinglearnresearchcommunity

for

Search:↓

Both concentrations of triamcinolone acetonide are equally effective and safe for treating patchy alopecia areata.

Topical flutamide works as well as hydroquinone for melasma but needs more safety checks.

A 6-year-old girl with alopecia universalis regrew most of her hair after treatment with simvastatin/ezetimibe, minoxidil, and prednisolone.

The TrichoConcept™ line is effective for personalized hair loss treatments.

Cyproterone acetate can effectively treat idiopathic hirsutism, but ethinyl oestradiol and lynoestrenol may not always reduce hair growth.

Tectona grandis leaf extracts, especially with propylene glycol, may be promising for topical hair loss treatments.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

TCM is an effective and safe treatment for primary cicatricial alopecias.

SH-340 may improve skin barrier and help treat atopic dermatitis.

Topical ruxolitinib failed to regrow hair in a 66-year-old with alopecia areata.

The treatment is effective for mild alopecia areata but often causes mild side effects.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.

The new delivery system makes retinol and niacinamide more stable and effective for anti-aging and skin-brightening.

Melasma treatment is difficult, but combination therapies and personalized plans show promise.

Twice-weekly 5 mg betamethasone helps hair regrowth in alopecia areata.

Tofacitinib effectively treated a woman's severe symptoms from a rare autoimmune condition.

Posaconazole is a promising new treatment for toenail fungus.

Tryptanthrin effectively suppresses non-melanoma skin cancer and is safe for normal skin.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

Vismodegib is effective for basal cell carcinoma but has severe side effects.

Selumetinib causes skin and hair side effects in kids with NF1, affecting treatment and quality of life.

DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.

New treatments for skin aging will soon compete with current ones like tretinoin.

Terbinafine effectively stops fungal invasion of human keratin.

Tofacitinib was found to be a safe and effective treatment for hair regrowth in patients with alopecia areata.

Ritlecitinib is effective and safe for long-term use in treating severe alopecia areata in people aged 12 and older.

A 93-year-old woman developed a rare scalp condition after therapy, which improved with steroids, not antibiotics.

A man with severe hair loss regrew all his hair using tofacitinib and stayed healthy for a year.